Scholar Rock Holding SRRK
NASDAQ SRRK
$55.11 -0.83 (-1.48%)
As of: Sep 4, 2026 · 12:51 PM EDT

Scholar Rock Holding (SRRK) Profit After Tax (2017 - 2026)

Scholar Rock Holding (SRRK) posted quarterly Profit After Tax of -$105.5 million for Q1 2026, down 41.2% year-over-year from -$179.4 million in Q1 2025, and down 458639.13% quarter-over-quarter from -$23000.0 in Q4 2025.

Analysis

Scholar Rock Holding (SRRK) Profit After Tax (2017 - 2026) Analysis & Trends

Scholar Rock Holding's Profit After Tax history runs 10 years deep, the most recent figure standing at -$105.5 million for Q1 2026.

  • In Q1 2026, Profit After Tax fell 41.2% year-over-year to -$105.5 million; the TTM figure through Mar 2026 stood at -$317.7 million (down 60.73% YoY), while the FY2025 annual figure was -$66000.0, down 197.06% from the prior year.
  • Profit After Tax for Q1 2026 stood at -$105.5 million, down from -$23000.0 in the prior quarter.
  • The five-year high for Profit After Tax was $32000.0 in Q4 2024, with the low at -$110.0 million in Q2 2025.
  • The 5-year median for Profit After Tax is -$44.0 million (2022), against an average of -$51.4 million.
  • The sharpest annual moves came in 2023 and 2024: Profit After Tax tumbled 395.33% in 2023, then jumped 100.07% in 2024.
  • Scholar Rock Holding's Profit After Tax stood at -$39.2 million in 2022, then declined by 19.86% to -$47.0 million in 2023, then surged by 100.07% to $32000.0 in 2024, then plunged by 171.88% to -$23000.0 in 2025, then slumped by 458639.13% to -$105.5 million in 2026.
  • Business Quant data shows SRRK's Profit After Tax at -$105.5 million in Q1 2026, -$23000.0 in Q4 2025, and -$102.2 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Vertex Pharmaceuticals 139.62 Bn 131.77 Bn 2.84 Bn 1.10 Bn
2 Regeneron Pharmaceuticals 85.73 Bn 77.73 Bn 3.93 Bn 1.30 Bn
3 Argenx Se 63.53 Bn 58.35 Bn 1.37 Bn 472.00 Mn
4 Moderna 58.23 Bn 53.09 Bn 52.00 Mn -782.00 Mn
5 Revolution Medicines 44.05 Bn 44.05 Bn - -644.37 Mn
6 BeOne Medicines 40.03 Bn 34.93 Bn 1.53 Bn 237.01 Mn
7 Alnylam Pharmaceuticals 35.50 Bn 32.19 Bn 992.69 Mn 164.49 Mn
8 Royalty Pharma 28.52 Bn 27.68 Bn - 81.49 Mn
9 Insmed 27.46 Bn 26.30 Bn 358.27 Mn -16.62 Mn
10 Scholar Rock Holding 7.21 Bn 7.21 Bn - -109.90 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -109.90 Mn
Mar 31, 2026 -105.51 Mn
Dec 31, 2025 -90.99 Mn
Sep 30, 2025 -102.22 Mn
Jun 30, 2025 -110.10 Mn
Mar 31, 2025 -74.72 Mn
Dec 31, 2024 -66.45 Mn
Sep 30, 2024 -64.48 Mn
Jun 30, 2024 -58.51 Mn
Mar 31, 2024 -56.85 Mn
Dec 31, 2023 -46.09 Mn
Sep 30, 2023 -42.36 Mn
Jun 30, 2023 -37.93 Mn
Mar 31, 2023 -39.38 Mn
Dec 31, 2022 -39.20 Mn
Sep 30, 2022 -44.15 Mn
Jun 30, 2022 -44.00 Mn
Mar 31, 2022 -7.95 Mn
Dec 31, 2021 -35.95 Mn
Sep 30, 2021 -37.52 Mn